Comprehensive Study of Atorvastatin Nanostructured Lipid Carriers through Multivariate Conceptualization and
Heba A Ghanem1, Ali M Nasr2,3, Tamer H Hassan4
1Department of Pharmaceutics, Faculty of Pharmacy, Sinai University, Al Qantarah Sharq 41636, Egypt.
This study optimized Atorvastatin-loaded nanostructured lipid carriers (AT-NLCs) for improved drug delivery. The developed AT-NLCs effectively reduced cholesterol and triglycerides in rats, showing potential for cardiovascular disease treatment.
Area of Science:
- Pharmaceutical Sciences
- Nanotechnology
- Drug Delivery Systems
Background:
- Hyperlipidemia is a major risk factor for cardiovascular diseases.
- Nanostructured lipid carriers (NLCs) offer enhanced drug delivery and stability.
- Atorvastatin is a widely used statin for managing hyperlipidemia.
Purpose of the Study:
- To develop and optimize Atorvastatin-loaded nanostructured lipid carriers (AT-NLCs).
- To evaluate the physicochemical properties and in vivo efficacy of AT-NLCs.
- To establish a robust experimental design for NLC formulation.
Main Methods:
- Utilized D-optimal screening and central composite designs for formulation optimization.
- Investigated factors including lipid composition, surfactant concentration, and processing parameters.
- Characterized AT-NLCs for particle size, PDI, zeta potential, and entrapment efficiency.
- Assessed drug-excipient compatibility using FTIR and DSC.
- Evaluated in vivo lipid-lowering effects in a rat model.
Main Results:
- Optimized AT-NLCs exhibited nanometric size (83.80 nm), favorable PDI (0.38), negative zeta potential (-29.65 mV), and high entrapment efficiency (93.1%).
- FTIR and DSC confirmed no chemical interactions and amorphous state of Atorvastatin within NLCs.
- Oral administration of AT-NLCs significantly reduced serum total cholesterol, triglycerides, and LDL levels in rats (p < 0.001).
- Histological analysis confirmed reduced liver steatosis.
Conclusions:
- The developed experimental design effectively optimized AT-NLCs.
- Optimized AT-NLCs demonstrate excellent physicochemical properties and high Atorvastatin loading.
- AT-NLCs show significant potential as an effective drug delivery system for hyperlipidemia management.
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Bioavailability Enhancement: Drug Permeability Enhancement
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...


